Review



wild type k562 cells  (DSMZ)


Bioz Verified Symbol DSMZ is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    DSMZ wild type k562 cells
    Wild Type K562 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 97/100, based on 769 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/pm42844479-569-0-3
    Average 97 stars, based on 769 article reviews
    wild type k562 cells - by Bioz Stars, 2026-10
    97/100 stars

    Images

    Related Articles

    Multiplex Assay:

    Article Title: ACSL4-associated lipid metabolism is a distinct therapeutic vulnerability in KMT2A-rearranged acute myeloid leukemia.
    Article Snippet: .. Cell lines THP1, NOMO1, K562, MOLM16, MV4-11, U937, and HEK293T were obtained from DSMZ and continuously tested for mycoplasma and cross-contamination by Multiplex Cell Authentication (Multiplexion, Heidelberg, Germany). ..

    other:

    Article Title: METTL16 inhibitors and uses thereof
    Article Snippet: U937, HEL, THP1, K562, MV4-11, RS4-11 and SUP-B15 were purchased from the American Type Culture Collection, and NOMO-1, ML-2, NB4 and MONOMAC-6 were obtained from DSMZ.

    Cell Culture:

    Article Title: A measles virus encoding a CD19/CD3 bispecific T-cell engager shows enhanced preclinical anti-BCP-ALL efficacy without significant toxicity
    Article Snippet: .. 297 Jo urn al Pr e-p roo f 13 Material and methods 298 299 Cells and cell culture 300 The producer cell line Vero, the leukemic cell lines REH, Jurkat, K562 and HAL-01, as well as the 301 neuroblastoma cell line SH-SY5Y, were obtained from DSMZ (Braunschweig, Germany). .. The murine 302 feeder cell line OP9 was procured from the American Type Culture Collection (ATCC, Manassas, VA).



    Similar Products

    99
    ATCC cell lines k562
    Cell Lines K562, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/pm42844288-252-6-9
    Average 99 stars, based on 1 article reviews
    cell lines k562 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    97
    DSMZ wild type k562 cells
    Wild Type K562 Cells, supplied by DSMZ, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/pm42844479-569-0-3
    Average 97 stars, based on 1 article reviews
    wild type k562 cells - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    99
    ATCC imatinib resistant k562 r
    Imatinib Resistant K562 R, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K562-r/10__3390_slash_biomedicines14102198-67-15-17
    Average 99 stars, based on 1 article reviews
    imatinib resistant k562 r - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC experimental models hek 293t atcc crl 3216 hela atcc ccl 2 k562 atcc ccl 243 n2a atcc ccl
    Experimental Models Hek 293t Atcc Crl 3216 Hela Atcc Ccl 2 K562 Atcc Ccl 243 N2a Atcc Ccl, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/pm42800828-181-12-15
    Average 99 stars, based on 1 article reviews
    experimental models hek 293t atcc crl 3216 hela atcc ccl 2 k562 atcc ccl 243 n2a atcc ccl - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC leukemia cell lines k562
    Leukemia Cell Lines K562, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/pm42556264-245-1-10
    Average 99 stars, based on 1 article reviews
    leukemia cell lines k562 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    ATCC k562 leukemia cells
    K562 Leukemia Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/10__69523_slash_sej__2026__42__17378-37-2-8
    Average 99 stars, based on 1 article reviews
    k562 leukemia cells - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    k-562  (ATCC)
    99
    ATCC k-562
    K 562, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/custom%40ccl-243%4042473281
    Average 99 stars, based on 1 article reviews
    k-562 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    99
    Thermo Fisher k562
    K562, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/Triton+X-100/pm42364663-101-4-9
    Average 99 stars, based on 1 article reviews
    k562 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    k562  (ATCC)
    99
    ATCC k562
    Expression of ALDH3A2 in healthy people and patients with AML (A) The expression of ALDH3A2 in various tumors compared with normal tissues. Data are represented as mean ± SEM. (B) Expression of ALDH3A2 in 88 leukemia cell lines. (C) The survival curve of patients with high and low expression of ALDH3A2 (n [low expression] = 121, n [high expression] = 30). (D) The expression of protein ALDH3A2 in HL-60, HL-60/ADM, <t>K562,</t> K562/ADM, and bone marrow in patients. (E) The expression of ALDH3A2 RNA in bone marrow mononuclear cells of AML patients in the CR ( n = 9), C1NR ( n = 8), and R/R ( n = 10) group. Data are represented as mean ± SEM. (F) The expression of ALDH3A2 in bone marrow mononuclear cells of 3 AML patients at their initial and recurrent stage. (G) High/low expression of ALDH3A2 and molecular mutation distribution of 66 AML patients. Data are represented as mean ± SEM. Ns indicates no statistical difference between the two groups, ∗ indicates p < 0.05 between the two groups. Statistical significance was determined using unpaired two-tailed Student’s t tests for the comparison of two groups.
    K562, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/k562/K-562/pmc13254865-41-0-2
    Average 99 stars, based on 1 article reviews
    k562 - by Bioz Stars, 2026-10
    99/100 stars
      Buy from Supplier

    Image Search Results


    Expression of ALDH3A2 in healthy people and patients with AML (A) The expression of ALDH3A2 in various tumors compared with normal tissues. Data are represented as mean ± SEM. (B) Expression of ALDH3A2 in 88 leukemia cell lines. (C) The survival curve of patients with high and low expression of ALDH3A2 (n [low expression] = 121, n [high expression] = 30). (D) The expression of protein ALDH3A2 in HL-60, HL-60/ADM, K562, K562/ADM, and bone marrow in patients. (E) The expression of ALDH3A2 RNA in bone marrow mononuclear cells of AML patients in the CR ( n = 9), C1NR ( n = 8), and R/R ( n = 10) group. Data are represented as mean ± SEM. (F) The expression of ALDH3A2 in bone marrow mononuclear cells of 3 AML patients at their initial and recurrent stage. (G) High/low expression of ALDH3A2 and molecular mutation distribution of 66 AML patients. Data are represented as mean ± SEM. Ns indicates no statistical difference between the two groups, ∗ indicates p < 0.05 between the two groups. Statistical significance was determined using unpaired two-tailed Student’s t tests for the comparison of two groups.

    Journal: iScience

    Article Title: ALDH3A2-mediated fatty acid synthesis induces ferroptosis and AML drug resistance

    doi: 10.1016/j.isci.2026.116202

    Figure Lengend Snippet: Expression of ALDH3A2 in healthy people and patients with AML (A) The expression of ALDH3A2 in various tumors compared with normal tissues. Data are represented as mean ± SEM. (B) Expression of ALDH3A2 in 88 leukemia cell lines. (C) The survival curve of patients with high and low expression of ALDH3A2 (n [low expression] = 121, n [high expression] = 30). (D) The expression of protein ALDH3A2 in HL-60, HL-60/ADM, K562, K562/ADM, and bone marrow in patients. (E) The expression of ALDH3A2 RNA in bone marrow mononuclear cells of AML patients in the CR ( n = 9), C1NR ( n = 8), and R/R ( n = 10) group. Data are represented as mean ± SEM. (F) The expression of ALDH3A2 in bone marrow mononuclear cells of 3 AML patients at their initial and recurrent stage. (G) High/low expression of ALDH3A2 and molecular mutation distribution of 66 AML patients. Data are represented as mean ± SEM. Ns indicates no statistical difference between the two groups, ∗ indicates p < 0.05 between the two groups. Statistical significance was determined using unpaired two-tailed Student’s t tests for the comparison of two groups.

    Article Snippet: K562 , ATCC , CCL-243.

    Techniques: Expressing, Mutagenesis, Two Tailed Test, Comparison

    ALDH3A2-V protects AML cells from ferroptosis and cytotoxicity induced by doxorubicin (A) ALDH3A2 mRNA relative expression in HL-60/ADM and K562/ADM cells after transfection of siRNA by electroporation. Data are represented as mean ± SEM. The specific data are shown in the supplemental table . (B) The lipid peroxidation degree of HL60ADM and K562ADM cells in the control (ctrl) and ALDH3A2 knockdown (KD) groups after the same dose of doxorubicin treatment for 48 h. (C) The content of ALDH3A2 protein in HL-60, K562, U937, and KG-1α in the ALDH3A2 overexpressing (OE) group and the control (CON) group. (D) The location of ALDH3A2-V overexpression. This representative image was selected from 3 independent replicate experiments, with 4 fields of view evaluated per replicate. (E) Lipid peroxidation in HL-60, K562, U937, and KG-1α in the ALDH3A2 OE group and the CON group under the same concentration of doxorubicin treatment. (F and G) Cell viability and its fitting curve of HL-60, K562, U937, and KG-1α in the ALDH3A2 OE group and the CON group under the gradient concentration of doxorubicin treatment. Data are represented as mean ± SEM. The specific data are shown in the supplemental table . Ns indicates no statistical difference between the two groups, ∗ indicates p < 0.05 between the two groups, and ∗∗ indicates p < 0.01 between the two groups. Statistical significance was determined using unpaired two-tailed Student’s t tests for the comparison of two groups.

    Journal: iScience

    Article Title: ALDH3A2-mediated fatty acid synthesis induces ferroptosis and AML drug resistance

    doi: 10.1016/j.isci.2026.116202

    Figure Lengend Snippet: ALDH3A2-V protects AML cells from ferroptosis and cytotoxicity induced by doxorubicin (A) ALDH3A2 mRNA relative expression in HL-60/ADM and K562/ADM cells after transfection of siRNA by electroporation. Data are represented as mean ± SEM. The specific data are shown in the supplemental table . (B) The lipid peroxidation degree of HL60ADM and K562ADM cells in the control (ctrl) and ALDH3A2 knockdown (KD) groups after the same dose of doxorubicin treatment for 48 h. (C) The content of ALDH3A2 protein in HL-60, K562, U937, and KG-1α in the ALDH3A2 overexpressing (OE) group and the control (CON) group. (D) The location of ALDH3A2-V overexpression. This representative image was selected from 3 independent replicate experiments, with 4 fields of view evaluated per replicate. (E) Lipid peroxidation in HL-60, K562, U937, and KG-1α in the ALDH3A2 OE group and the CON group under the same concentration of doxorubicin treatment. (F and G) Cell viability and its fitting curve of HL-60, K562, U937, and KG-1α in the ALDH3A2 OE group and the CON group under the gradient concentration of doxorubicin treatment. Data are represented as mean ± SEM. The specific data are shown in the supplemental table . Ns indicates no statistical difference between the two groups, ∗ indicates p < 0.05 between the two groups, and ∗∗ indicates p < 0.01 between the two groups. Statistical significance was determined using unpaired two-tailed Student’s t tests for the comparison of two groups.

    Article Snippet: K562 , ATCC , CCL-243.

    Techniques: Expressing, Transfection, Electroporation, Control, Knockdown, Over Expression, Concentration Assay, Two Tailed Test, Comparison